Rockwell Medical (RMTI) Change in Account Payables (2010 - 2026)
Rockwell Medical (RMTI) posted Change in Account Payables of $1.4 million for Q1 2026, up 205.06% on a QoQ basis from $474000.0 in Q4 2025, and up 253.18% year-over-year from $409425.3 in Q1 2025.
Rockwell Medical (RMTI) Change in Account Payables (2010 - 2026) Analysis & Trends
Rockwell Medical's Change in Account Payables history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- Quarterly Change in Account Payables rose 253.18% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 150.77% YoY) and the FY2025 annual result came in at -$870000.0, up 47.18% from the prior year.
- Change in Account Payables was $1.4 million for Q1 2026 at Rockwell Medical, up from $474000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.4 million in Q1 2026 and bottomed at -$2.0 million in Q3 2023.
- A 5-year average of -$17294.1 and a median of $262000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables tumbled 1933.03% — and 2026, when it soared 253.18%.
- Rockwell Medical's Change in Account Payables stood at $1.0 million in 2022, then slumped by 41.42% to $587000.0 in 2023, then plunged by 55.37% to $262000.0 in 2024, then surged by 80.92% to $474000.0 in 2025, then surged by 205.06% to $1.4 million in 2026.
- Business Quant data shows RMTI's Change in Account Payables at $1.4 million in Q1 2026, $474000.0 in Q4 2025, and $23000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.45 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 474,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | -423,000.00 |
| Jun 30, 2025 | -423,000.00 |
| Mar 31, 2025 | -944,000.00 |
| Mar 31, 2025 | -944,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Sep 30, 2024 | -740,000.00 |
| Sep 30, 2024 | -740,000.00 |
| Jun 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | 403,000.00 |
| Mar 31, 2024 | 403,000.00 |
| Dec 31, 2023 | 587,000.00 |
| Dec 31, 2023 | 587,000.00 |